Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
PRNewswireMumbai (Maharashtra) [India], July 7: Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness…
